Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$235.67 +2.66 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Asset Writedowns and Impairment (2014 - 2023)

Updated

Jazz Pharmaceuticals' Asset Writedowns and Impairment came in at $61.01 million for Q4 2023.

Analysis

Jazz Pharmaceuticals (JAZZ) Asset Writedowns and Impairment (2014 - 2023) Analysis & Trends

Going back to Q2 2014, Jazz Pharmaceuticals' Asset Writedowns and Impairment data covers 7 quarters.

  • Asset Writedowns and Impairment carries a five-year compound annual growth rate of 7.3% (FY2018 to FY2023).
  • Going back by year, Asset Writedowns and Impairment was $133.65 million in FY2022 and $136.14 million in FY2020.
  • The Q4 2023 figure represents the highest quarterly Asset Writedowns and Impairment since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Jazz Pharmaceuticals 15.30 Bn 9.12 Bn 1.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 61.01 Mn
Sep 30, 2022 133.65 Mn
Mar 31, 2020 136.14 Mn
Jun 30, 2018 42.90 Mn
Dec 31, 2015 31.52 Mn
Dec 31, 2014 6.60 Mn
Jun 30, 2014 32.80 Mn
API Access

Jazz Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=JAZZ&period=max&api_key=YOUR_API_KEY